EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)Frank Tacke, Dror Dicker, Paul Horn et al.|Journal of Hepatology|2024Cited by 1.6k
Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic FactorsAnna Kotronen, Hannele Yki‐Järvinen|Gastroenterology|2009Cited by 804
FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic studyAnu Suomalainen, Henna Tyynismaa, Hannele Yki‐Järvinen et al.|The Lancet Neurology|2011Cited by 420
Quantitative PCR provides a simple and accessible method for quantitative microbiota profilingChing Jian, Katri Korpela, Panu K. Luukkonen et al.|PLoS ONE|2020Cited by 385
Exposure to environmental contaminants is associated with altered hepatic lipid metabolism in non-alcoholic fatty liver diseasePartho Sen, Tuulia Hyötyläinen, S. U. Qadri et al.|Journal of Hepatology|2021Cited by 280